Notice of Application - 2011

• Mylan Pharmaceuticals, Inc. (December 29, 2011)
• Hospira Inc. (December 12, 2011)
• Johnson Matthey, Inc. (December 12, 2011)
• Fisher Clinical Services, Inc. (October 7, 2011)
• Cody Laboratories Inc. (October 7, 2011)
• Cambrex Charles City, Inc. (August 18, 2011)
• Cambrex Charles City, Inc. (August 18, 2011)
• Aptuit (August 18, 2011)
• Roche Diagnostics Operations Inc. (July 19, 2011)
• United States Pharmacopeial Convention (July 19, 2011)
• Research Triangle Institute (July 5, 2011)
• Penick Corporation (June 16, 2011)
• Boehringer Ingelheim Chemicals, Inc. (June 16, 2011)
• Noramco Inc. (June 16, 2011)
• Lipomed, Inc. (June 16, 2011)
• Wildlife Laboratories (June 16, 2011)
• Chattem Chemicals Inc. (June 16, 2011)
• Noramco Inc. (June 16, 2011)
• AllTech Associates Inc. (June 9, 2011)
• Almac Clinical Services Inc. (ACSI) (May 27, 2011)
• Akorn, Inc. (May 27, 2011)
• Rhodes Technologies (May 4, 2011)
• Stepan Company (April 19, 2011)
• Meda Pharmaceuticals Inc. (April 19, 2011)
• Aptuit (March 17, 2011)
• Sigma Aldrich Manufacturing LLC. - Correction (March 4, 2011)
• Sigma Aldrich Manufacturing LLC. (February 23, 2011)
• Mallinckrodt Inc. (February 2, 2011)

NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO).